Hospital
West Boca Medical Center, INC.
West Boca Medical Center, INC. was paid $13.41M by Medicaid between Jan 2018 and Dec 2024, across 155 billing codes. Its largest line is 99284, emergency room visit (serious) — 16% of everything it billed.
33Billing provider infoWEST BOCA MEDICAL CENTER, INC.
BOCA RATON, FL 33428
BOCA RATON, FL 33428
33aNPI1588697296assigned 07/08/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$13.41M
24GClaims323,415
24DCodes billed155
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#37 of 163
Median peer was paid$4.77M
This provider vs. median2.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,602 | $286K | |
| 2019 | 70,122 | $1.50M | |
| 2020 | 50,104 | $1.14M | |
| 2021 | 71,744 | $2.79M | |
| 2022 | 77,001 | $5.32M | |
| 2023 | 30,769 | $1.87M | |
| 2024incomplete | 9,073 | $512K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 14,931 | 13,293 | $2.16M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 18,609 | 16,882 | $2.07M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 7,612 | 6,599 | $1.71M |
| 70450 | Computed tomography, head or brain; without contrast material | 7.1% | 2,829 | 2,465 | $956K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 6.4% | 5,843 | 1,520 | $860K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.9% | 1,140 | 1,013 | $787K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 3.3% | 10,199 | 2,317 | $445K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.2% | 5,125 | 1,380 | $433K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.2% | 959 | 833 | $431K |
| 80053 | Comprehensive metabolic panel | 2.8% | 15,487 | 12,764 | $379K |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 2.7% | 1,876 | 1,438 | $359K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.0% | 2,643 | 2,421 | $274K |
143 more codes
| 30140 | 2.0% | 149 | $267K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1.8% | 653 | $242K |
| G0378 | Hospital observation service, per hour | 1.7% | 4,444 | $229K |
| 81001 | 1.7% | 11,707 | $225K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.5% | 5,868 | $204K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 7,810 | $115K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 2,539 | $92K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,149 | $90K |
| J3490 | Unclassified drugs | <1% | 446 | $79K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 3,335 | $73K |
| S0028 | Injection, famotidine, 20 mg | <1% | 1,627 | $68K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,085 | $64K |
| 87070 | <1% | 5,393 | $60K | |
| 59025 | Fetal non-stress test | <1% | 2,699 | $52K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 8,263 | $51K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 79 | $44K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 124 | $35K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,456 | $33K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,836 | $32K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,218 | $25K |
| 87420 | <1% | 2,187 | $24K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 384 | $23K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 724 | $22K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,697 | $22K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 596 | $21K |
| 74018 | <1% | 1,000 | $19K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 18,733 | $17K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 933 | $17K |
| 71045 | Radiologic examination, chest; single view | <1% | 5,974 | $17K |
| 42830 | <1% | 135 | $16K | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 610 | $15K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 97 | $14K |
| 97162 | <1% | 244 | $13K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 6,562 | $13K |
| 81025 | <1% | 1,775 | $12K | |
| A4217 | Sterile water/saline, 500 ml | <1% | 1,028 | $12K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 326 | $11K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 14 | $10K |
| 82962 | <1% | 2,353 | $10K | |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 1,712 | $9K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 640 | $9K |
| 73630 | <1% | 585 | $9K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 710 | $8K |
| 86850 | <1% | 1,554 | $7K | |
| 73610 | <1% | 347 | $6K | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 198 | $6K |
| 87632 | <1% | 687 | $5K | |
| 94664 | <1% | 2,173 | $5K | |
| 85610 | <1% | 4,504 | $4K | |
| 84702 | <1% | 1,295 | $4K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,973 | $4K |
| 85730 | <1% | 4,400 | $4K | |
| 76830 | Ultrasound, transvaginal | <1% | 90 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,111 | $4K |
| 84703 | <1% | 2,653 | $3K | |
| 87040 | <1% | 3,716 | $3K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,608 | $3K |
| 76641 | <1% | 43 | $3K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 15 | $3K |
| A9270 | Non-covered item or service | <1% | 1,579 | $3K |
| 82550 | <1% | 1,874 | $3K | |
| 73130 | <1% | 219 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 8,112 | $2K |
| 87186 | <1% | 782 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 93 | $2K |
| 76770 | <1% | 55 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,044 | $2K |
| 87077 | <1% | 849 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,982 | $2K |
| 12011 | <1% | 58 | $2K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 4,756 | $2K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 4,437 | $2K |
| 73562 | <1% | 196 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,154 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,615 | $1K |
| 76801 | <1% | 306 | $1K | |
| 74022 | <1% | 292 | $1K | |
| 87631 | <1% | 13 | $1K | |
| 84484 | <1% | 3,188 | $1K | |
| 76857 | <1% | 147 | $1K | |
| 83690 | <1% | 3,035 | $1K | |
| J2704 | Injection, propofol, 10 mg | <1% | 3,714 | $951.90 |
| 88304 | <1% | 111 | $874.31 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 5,449 | $813.64 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,193 | $811.41 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,241 | $789.36 |
| 86140 | <1% | 3,831 | $754.40 | |
| 74019 | <1% | 104 | $732.60 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 27 | $655.07 |
| 83605 | <1% | 723 | $620.82 | |
| 85379 | <1% | 568 | $620.05 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 2,132 | $565.71 |
| 83735 | <1% | 1,427 | $450.38 | |
| 73110 | <1% | 82 | $446.16 | |
| 86900 | <1% | 1,769 | $433.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 509 | $427.42 |
| 85027 | <1% | 212 | $402.82 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,910 | $387.30 |
| 83880 | <1% | 295 | $344.52 | |
| 73090 | <1% | 12 | $305.05 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 815 | $303.95 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 596 | $286.85 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 452 | $266.81 |
| 86901 | <1% | 1,769 | $262.39 | |
| 96376 | <1% | 814 | $246.54 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 171 | $244.95 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 815 | $227.13 |
| 82150 | <1% | 684 | $213.91 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 677 | $207.43 |
| 85652 | <1% | 546 | $201.10 | |
| 87088 | <1% | 475 | $199.77 | |
| 82731 | <1% | 13 | $123.33 | |
| 87210 | <1% | 12 | $122.34 | |
| 84439 | <1% | 126 | $62.11 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,449 | $59.25 |
| 94760 | <1% | 42 | $37.14 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 240 | $34.95 |
| 73030 | <1% | 30 | $2.37 | |
| 84100 | <1% | 23 | $1.57 | |
| S0077 | Injection, clindamycin phosphate, 300 mg | 0% | 13 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 119 | $0.00 |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 0% | 2,073 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 180 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 497 | $0.00 |
| 87045 | 0% | 17 | $0.00 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 21 | $0.00 |
| 84550 | 0% | 27 | $0.00 | |
| A4649 | Surgical supply; miscellaneous | 0% | 106 | $0.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 42 | $0.00 |
| 54161 | 0% | 12 | $0.00 | |
| 00920 | 0% | 12 | $0.00 | |
| 86308 | 0% | 84 | $0.00 | |
| 00160 | 0% | 133 | $0.00 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 0% | 98 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 17 | $0.00 |
| 00126 | 0% | 73 | $0.00 | |
| J3590 | Unclassified biologics | 0% | 26 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 18 | $0.00 |
| J1741 | Injection, ibuprofen, 100 mg | 0% | 275 | $0.00 |
| 87205 | 0% | 59 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 118 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 18 | $0.00 |
| 93971 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCOLE, KIM (CFO)
| Provider | Location | Paid |
|---|---|---|
| Palm Beach Gardens Community Hospital, INC. | Palm Beach Gardens, FL | $3.17M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.